Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...
EGOT winner Whoopi Goldberg railed against an ad that's circulating on social media with a manipulated version of her ...
With weight loss drugs such as Ozempic and Mounjaro seemingly able to melt the pounds away, you might well think you'll never need a 'diet plan' again. Alas, you'd be wrong. As a leading weight ...
A charity boss who struggled for years to shed pounds despite having undergone surgery has hailed weight-loss jabs as ...
What is Mounjaro and how does the weight-loss jab work? Pharmacies to face stricter checks for popular drug - Pharmacists who ...
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
Eli Lilly and Company LLY will report its fourth-quarter and full-year 2024 earnings on Feb. 6, before market open. The Zacks ...
Demand for weight loss jabs continues to surge, particularly as the NHS began offering Wegovy in late 2023 and will start offering Mounjaro to patients in March 2025. They have also become ...
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
Vegetables for weight loss: Eating these vegetables could do wonders for weight loss. Belly fat isn't just an eyesore and severely impacts our self-image as well as our confidence, moreover ...
Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.
the active ingredient in Eli Lilly’s popular weight loss medication Zepbound and diabetes drug Mounjaro. After months of high demand and supply constraints, this news marks a significant ...